Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Quadriga Biosciences, Inc.
Tocagen Inc.
INSYS Therapeutics Inc
Novartis
Siemens Molecular Imaging